RayThera

Biotech & Life Sciences · San Diego, United States · Founded 2023

RayThera is a small molecule drug discovery company focused on developing therapies for immunological diseases with significant unmet medical needs. Founded in August 2023, the company leverages decades of drug discovery expertise to accelerate the development of safer and more effective therapeutics. RayThera operates in the pharmaceutical and biotechnology market, targeting healthcare providers and patients requiring advanced treatment options for immunological conditions. The business model centers on research and development, progressing from target identification to clinical trials, with revenue generated through partnerships, licensing agreements, and eventual product sales. The company's approach is characterized by a nimble and adaptable development process, ensuring rigorous standards are maintained throughout. RayThera collaborates with clinical trial partners to ensure compliance with global privacy and data protection regulations. Keywords: small molecule, drug discovery, immunology, therapeutics, clinical trials, healthcare, pharmaceutical, biotechnology, development, partnerships.

Valuation $100–500M

Total funding $100–500M

Unlock exact values

Investors

3 investors on RayThera's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

OrbiMed

Foresite Capital

TTM Capital

Global footprint

Where RayThera has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Talent graph

The shape of RayThera's talent

Dealroom maps RayThera's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

2 team members profilednamed & role-tagged by Dealroom

2 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock RayThera's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about RayThera

An AI-synthesized read of the highest-engagement posts about RayThera on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RayThera on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles